ARTICLE | Clinical News
Idera preclinical data
March 16, 2009 7:00 AM UTC
In mouse tumor models, an immune modulatory oligonucleotide (IMO) agonist of toll-like receptor 9 (TLR9) in combination with a DNA electroporation/adenovirus (DNA-EP/Ad) vaccine against epidermal gr...